Recent NARI Stock Price | NARI Stock Predictions | |
$38.07 | +93.59% |
$73.70 |
Recent NARI Analyst Ratings Breakdown, Making NARI Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 6 | 6 | 7 | 7 |
Buy ratings: | 1 | 1 | 1 | 1 |
Hold ratings: | 2 | 2 | 1 | 1 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.56 | 1.56 | 1.33 | 1.33 |
For the NARI stock predictions from the analysts covering Inari Medical Inc, we have collected all of the individual NARI stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 10 different analysts covering NARI (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since NARI stock predictions may vary widely, another useful metric to consider is the median NARI stock prediction, which represents the price at which half of the analysts
made NARI stock predictions that were higher and half made NARI stock predictions that were lower. This makes for a different take on the NARI stock predictions out there, as compared to average or mean.
And that median across all the individual NARI stock predictions was: $73.5 as of 2024-04-26.
The very highest of the NARI stock predictions for one year price target was $100.0, while the very lowest of the NARI stock predictions in the analyst group was
$47.0 (with a standard deviation of $15.86). Get the latest Zacks research report on NARI — FREE
Find out: NARI next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
DESP Stock Predictions
OOMA Stock Predictions
TZOO Stock Predictions
SRGA Stock Predictions
OUT Stock Predictions
AGR Stock Predictions
KMB Stock Predictions
CAAP Stock Predictions
SBCF Stock Predictions
|
|
Buy (3.44 out of 4) 57th percentile
(ranked higher than approx. 57% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |